July 29, 2011

PharmaCline on Thursday announced it has secured the worldwide rights for drug delivery technology and existing antibiotic products from Phillips Co. that will enable production of a well-tolerated and broad-spectrum topical antibiotic.

February 18, 2011

A generic drug maker received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment.